Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
chronic kidney disease
deals
eli lilly
fremanezumab
immunotherapy
investing
medical device
medicare
What
companies
4
×
new
4
×
approval
drug
ipo
life
momentum
raised
science
week
arguments
arrival
big
bio
biogen’s
biopharmaceutical
biotech
biotechs
class
club
commercialized
competitors
continued
convo
crop
days
decades
drugs
earlier
exceeded
failures
fda
firms
group
hasn’t
haul
industry
ipos
joined
latest
Language
unset
Current search:
companies
×
national
×
new
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
